AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2017
Apr 27, 2017
34931_dirs_2017-04-27_b2259bd8-5416-4047-9588-aaea743e4956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2017-04-25
Reporting Person: Talamo Joseph (SVP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-25 | Common Stock | F | 214 | $4.74 | Disposed | 21601 | Direct |
Footnotes
F1: Includes 14,003 shares of unvested restricted stock.